Are you sure you want to hide the widget forever? If you need it back, please clear your cookies.
Content
Colors
Color Filters
Navigation
Selected Language
English (United States)
All Languages
Accessibility Statement
Our Commitment to Accessibility
We are committed to ensuring digital accessibility for people with disabilities. We are continually improving the user experience for everyone, and applying the relevant accessibility standards to help users with various disabilities access our website effectively.
Compliance Status
Our website strives to conform to the Web Content Accessibility Guidelines (WCAG) 2.1 Level AA standards. We also aim to be compliant with the Americans with Disabilities Act (ADA) and the European Accessibility Act requirements. These guidelines and regulations explain how to make web content more accessible to people with a wide range of disabilities. We acknowledge that some aspects of our website may not yet achieve full compliance, and we are actively working to address these areas.
Accessibility Features Available
Our website implements the Accessibly App, which provides a variety of tools to enhance website accessibility:
Visual Adjustments
Bigger Text: Increase text size up to 3x for better readability (WCAG 2.1/1.4.4)
Bigger Cursor: Enhanced cursor visibility for easier navigation
Color Adjustments: Invert colors, adjust contrast, brightness, and saturation
Grayscale Mode: Convert website to grayscale for users with visual impairments
Hide Images: Reduce visual distractions for easier reading
Reading and Navigation Aids
Reading Line: Adds a guide line to help follow text
Reading Mask: Places a mask over text to isolate lines and enhance focus
Readable Fonts: Converts to highly legible fonts for better comprehension
Highlight Links: Makes links more prominent for easier navigation
Dyslexic Fonts: Special typography for users with dyslexia
Page Structure: Simplified layout options for easier navigation
Assistive Technologies
Keyboard Navigation: Full website control using keyboard (Tab, Shift+Tab, Enter)
Alt Text for Images: AI-generated image descriptions where manual ones aren't provided
Read Page Aloud: Text-to-speech functionality
Stop Animations: Pause motion content for users with vestibular disorders
Limitations and Feedback
Despite our best efforts to ensure accessibility, there may be some limitations. Content provided by third parties, user-generated content, or certain legacy pages may not be fully accessible. We are continuously working to improve our website's accessibility.
We welcome your feedback on the accessibility of our website. If you encounter any barriers or have suggestions for improvement, please contact us. We are committed to addressing these issues promptly.
Technical Information
The accessibility features on this website are provided through the Accessibly App, which utilizes several technologies including HTML, CSS, JavaScript, and various frameworks to enhance accessibility. Our implementation strives to be compatible with major screen readers and assistive technologies.
Legal Disclaimer
While we strive to adhere to WCAG 2.1 Level AA standards and provide accessible content, we cannot guarantee that our website will be accessible to all users under all circumstances. This website is provided 'as is' without any representations or warranties, express or implied.
In no event shall we be liable for any damages arising from or related to:
Inability to access or use the website
Any alleged non-compliance with accessibility laws or regulations
Any disruption or errors in the functionality of accessibility features
By using this website, you agree to hold us harmless from any claims related to website accessibility issues. We are committed to addressing accessibility barriers in good faith but cannot guarantee immediate resolution in all cases.
Contact Us
If you have any questions about our accessibility efforts or encounter any barriers while using our website, please contact us.
Your medical cannabis journey simplified: find partnered dispensaries, explore pricing options, earn rewards, and get answers to FAQs, all in one spot.
Dr. Jae Sevelius (they/them) is a researcher and professor with the Department of Psychiatry at Columbia University who has dedicated their career to providing mental healthcare opportunities to members of the transgender (“trans”) and gender-diverse communities. Currently, their research and clinical work involves exploring the benefits of psychedelic-assisted therapy (PAT) using MDMA to treat identity-based trauma. Recent discoveries in clinical research on the therapeutic application of psychedelic substances, such as psilocybin or MDMA, have turned considerable scientific attention toward PAT as a promising treatment for certain mental health conditions. According to Dr. Sevelius’ work, there are important and unique ways that PAT can help transgender patients overcome past traumas.
What is Psychedelic-Assisted Therapy?
PAT involves using medically supervised administration of psychedelic drugs—such as MDMA, psilocybin, LSD and ketamine—in conjunction with psychotherapy to address certain persistent mental health conditions. Combining these two treatments has been suggested to enhance their success in providing mental health benefits.
Drugs classified as “psychedelics” (also called “hallucinogens”) are natural or synthetic psychoactive substances that affect human perception and mood, among other cognitive processes. Psychedelics are known to shift the ways individuals understand themselves, others and the world more generally, and these effects are especially important for people struggling with inflexible thought patterns that are common to many mental health disorders.
Numerous clinical trials suggest that psychedelics can be exceptionally effective for treating severe depression and post-traumatic stress disorder (PTSD). In fact, research involving MDMA and psilocybin has produced such strong evidence of success that the United States Food and Drug Administration (FDA) has recognized these two substances as “breakthrough therapies” for PTSD and depression.
However, because the US Drug Enforcement Administration (DEA) classifies psychedelics as Schedule I controlled substances, these drugs are considered addictive and have “no accepted medical use,” so they are generally illegal and difficult to obtain for medicinal application.
Psychedelic-Assisted Therapy and Trans Communities
Populations of transgender and gender-diverse people experience disproportionately high rates of PTSD compared to cisgender people, so the potential health benefits of MDMA-assisted therapy are particularly interesting for many individuals in these communities.
See If You Qualify For Medical Marijuana -Select Your State!
Throughout history and in societies across the globe, gender identities, expressions, and roles are found to be diverse, complex elements of various cultures. Trans and gender-diverse people generally are those who express and associate with a gender identity that does not conform with the cultural gender conventions attributed to the sex they were assigned at birth. Although no official U.S. census data are documenting trans populations, experts estimate that approximately 0.5 -3% of the U.S. population, about 1-9 million people, identify as trans or gender diverse.
Particularly in Western cultures, trans and gender-diverse people are often undermined and face discrimination or ridicule for expressing gender in ways that fail to conform to generally accepted social standards dictating the traditional gender binary. Thus, trans and gender-diverse populations are more likely to experience bullying, rejection, and victimization, which can even come from the people who are needed for support, like family members or healthcare providers. Transgender and gender-diverse people are also more likely to experience childhood sexual abuse than the general population. As a result, rates of trauma from stigma, abuse, and exclusion tend to be higher in trans and gender-diverse populations.
Experts are interested in the particular benefits that MDMA-assisted psychotherapy could offer trans and gender-diverse people experiencing “identity-based” or other forms of trauma. PAT using MDMA is a promising treatment for individuals overcoming traumatic events because of the way MDMA alters brain connectivity involving the prefrontal cortex—the part of the brain that supports conscious reasoning. The drug also acts on the amygdala—the region of the brain that processes fear—which is especially active in PTSD patients.
These effects allow the brain to process trauma differently while supporting feelings of self-compassion and compassion for others. Clinicians remark that in trans and gender-expansive people, these effects help to produce a kind of self-acceptance referred to as “internalized gender affirmation,” which allows transgender PTSD sufferers to overcome identity-based trauma and feel more fully self-expressed in spite of social stigma, oppression, and marginalization regarding their gender identities. In addition, psychedelic therapy can potentially reduce individuals’ need to find gender affirmation from other people.
Finding Affirmation Within
PAT can increase gender affirmation in multiple ways, and PAT using MDMA can help by facilitating self-compassion and feelings of self-love. Because MDMA therapy increases a person’s sense of trust, these medicines can reconnect trans and gender-diverse PTSD patients, who are often made to feel like outsiders, with themselves and with others. The overall hope is that these therapies can renew connections between clients and their identities as well as other socially supportive members of the community through activating increased self-compassion and a deeper understanding of how true affirmation comes from within.
Note: Veriheal does not support illegally consuming therapeutic substances like MDMA but acknowledges that it transpires because of the current illicit status of both, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting alternative therapies.
Sheldon Sommer is a Southern Californian philosopher with a lifelong interest in the biological world. She is enthusiastic to contribute her fascination with philosophy, natural history, psychology, botany, biochemistry and other related topics to providing cannabis education for the similarly curious. Outside of writing, she enjoys painting, singing opera and Taylor Swift songs, as well as spending quality time with a certain beloved orange kitty cat.
Migraines are far more debilitating than typical headaches, often disrupting daily life. More and more people are turning to cannabis to manage their chronic pain, with migraines being the top reason among headache patients. Cannabis is such a powerful tool for migraine and pain relief that many patients even use medical marijuana in place of…
We all know honey comes from bees, and bees need flowers to make honey, so does this mean bees can make infused honey from the flowers of the cannabis plant? The details are more complicated than you’d think. Cannabis flowers don’t produce nectar, so bees can’t make honey from them. Since cannabis plants pollinate via…
Let’s have a real conversation. Every year, when the Fourth of July rolls around, I see the fireworks and flags and hear all the loud talk about freedom. And every year, I find myself sitting here asking the same damn question: Whose freedom are we really celebrating? Because it sure as hell doesn’t feel like…
Over the last decade, there has been considerable discussion about the future of cannabis. Typically, those conversations center around legality, market size, and social and medical impacts, all of which are interesting topics in their own right. But there has been far less discussion about the digital future of cannabis. With more and more of…
When Johaness Gutenberg introduced his printing press in the mid-15th century, he sparked a revolution in the way the masses could spread and consume information. For centuries after, the primary way we shared content was through print media, like books and magazines. But when Tim Berners-Lee invented the World Wide Web in 1989, that all…
The statements made regarding cannabis products on this website have not been evaluated by the Food and Drug Administration (FDA). Cannabis is not an FDA-approved substance and is still illegal under federal law. The information provided on this website is intended for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It is not intended as medical advice and should not be considered as a substitute for advice from a healthcare professional. We strongly recommend that you consult with a physician or other qualified healthcare provider before using any cannabis products. The use of any information provided on this website is solely at your own risk.